Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
The American Review of Respiratory Disease|April 1, 1987
Transpulmonary angiotensin II formation in patients with chronic stable cor pulmonaleJ B Neilly, C J Clark, A Tweddel, et al.British Journal of Clinical Pharmacology|February 1, 1991
A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarctionJ D Gemmill, K J Hogg, J M Burns, et al.Journal of the American College of Cardiology|July 1, 1985
Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular functionS R Spielman, A M Greenspan, H R Kay, et al.British Heart Journal|August 1, 1992
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgGR Fears, H Ferres, E Glasgow, et al.Basic Research in Cardiology|January 1, 1996
Impaired matching of perfusion and ventilation in heart failure detected by 133xenonN P Lewis, A P Banning, J P Cooper, et al.The American Journal of Cardiology|February 1, 1985
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart diseaseL N Horowitz, A M Greenspan, S R Spielman, et al.Pharmacoepidemiology and Drug Safety|April 3, 2008
Developing tools for the safety specification in risk management plans: lessons learned from a pilot projectAndrew J P Cooper, Sally Lettis, Charlotte L Chapman, et al.Journal of the American College of Cardiology|July 1, 1986
Plasma norepinephrine in exercise-induced ventricular tachycardiaN M Sokoloff, S R Spielman, A M Greenspan, et al.Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.Pageof 10